Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1618240 | 0.84 | CA2 (0.48) | MAPK1SMN1; SMN2CA1CA2EPHX1 | |
| SCHEMBL1618000 | 0.84 | CA2 (0.34) | MAPK1SMN1; SMN2CA1CA2EPHX1 | |
| Trifluoroacetic Acid SCHEMBL27839155 | 0.76 | MAPK1 (0.42) | MAPK1SMN1; SMN2CA1CA2EPHX1 | |
| SCHEMBL4448130 | 0.74 | CA2 (0.35) | MAPK1SMN1; SMN2CA1CA2EPHX1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1861472 | 0.73 | ALDH1A1 (0.33) | EPHX1 | |
| SCHEMBL13271935 | 0.72 | MAPK1 (0.39) | MAPK1SMN1; SMN2CA1CA2EPHX1 | |
| SCHEMBL25787304 | 0.71 | EPHX1 (0.46) | CA1CA2EPHX1 | |
| Tetrylammonium SCHEMBL1618712 | 0.70 | CA2 (0.35) | MAPK1SMN1; SMN2CA1CA2EPHX1 | |
| SCHEMBL10076880 | 0.70 | CA1 (0.42) | MAPK1SMN1; SMN2CA1CA2EPHX1 | |
| Trifluoromethanesulfonic Acid SCHEMBL3225327 | 0.69 | GPR3 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1414088-B1 | NOVEL ONIUM SALT, ELECTROLYTE FOR NONAQUEOUS CELL CONTAINING THE NOVEL ONIUM SALT FOR NONAQUEOUS CELL, AND METHOD FOR OPTIMIZING A NEGATIVE ELECTRODE USING AN ELECTROLYTE CONTAINING THE ONIUM SALT | TOKUYAMA CORP (JP) | 2013-05-22 | — | — | EP | disclosed |
| US-20040170890-A1 | Novel onium salt, electrolyte for non-aqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using elecrolyte containing onium salt | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2004-09-02 | — | — | US | disclosed |
| EP-1414088-A1 | NOVEL ONIUM SALT, ELECTROLYTE FOR NONAQUEOUS CELL CONTAINING THE NOVEL ONIUM SALT FOR NONAQUEOUS CELL, AND METHOD FOR OPTIMIZING NEGATIVE ELECTRODE USING ELECTROLYTE CONTAINING ONIUM SALT | Tokuyama Corporation (JP) | 2004-04-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040170890-A1 | Novel onium salt, electrolyte for non-aqueous cell containing the novel onium salt for nonaqueous cell, and method for optimizing negative electrode using elecrolyte containing onium salt | ALPL, CACNA2D3, FASTKD5 | MAPK1 1317/4885SMN1; SMN2 1685/4885CA1 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.